EXHIBIT 10.4 KERYX BIOPHARMACEUTICALS, INC. 2002 CEO INCENTIVE STOCK OPTION PLAN SPECIAL NONSTATUTORY STOCK OPTION AGREEMENT 1. Grant of Option. This Agreement evidences the grant by Keryx Biopharmaceuticals, Inc., a Delaware corporation (the...Special Nonstatutory Stock Option Agreement • May 15th, 2003 • Keryx Biopharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMay 15th, 2003 Company Industry Jurisdiction
KERYX BIOPHARMACEUTICALS, INC. SPECIAL NONSTATUTORY STOCK OPTION AGREEMENTSpecial Nonstatutory Stock Option Agreement • May 7th, 2007 • Keryx Biopharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMay 7th, 2007 Company Industry
KERYX BIOPHARMACEUTICALS, INC. SPECIAL NONSTATUTORY STOCK OPTION AGREEMENTSpecial Nonstatutory Stock Option Agreement • May 7th, 2007 • Keryx Biopharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMay 7th, 2007 Company Industry
June 13, 2001 Entrust, Inc. One Preston Park South 4975 Preston Park Boulevard, Suite 400 Plano, Texas 75093 Re: Special Nonstatutory Stock Option Agreement dated April 22, 2001 by and between the Registrant and F. William Conner...Special Nonstatutory Stock Option Agreement • June 13th, 2001 • Entrust Inc • Services-computer programming services
Contract Type FiledJune 13th, 2001 Company IndustryWe have assisted in the preparation of a Registration Statement on Form S-8 (the "Registration Statement") to be filed with the Securities and Exchange Commission (the "Commission") under the Securities Act of 1933, as amended (the "Securities Act"), relating to an aggregate of 2,000,000 shares of Common Stock, $.01 par value per share (the "Shares"), of Entrust, Inc., a Maryland corporation (the "Company"), issuable under the Special Nonstatutory Stock Option Agreement dated April 22, 2001 by and between the Registrant and F. William Conner (the "Plan").